Navigation Links
unduly in Medical News

Do not get unduly stressed or emotional as it may affect the heart!

An old adage “prevention is better than cure” is the mantra for a new study that says avoid stress and emotions to keep a healthy heart. // Strategies to manage stress in Americans were discussed at the American forum. According to research 20 percent of Americans are worried that stress...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...chieve favorable clinical outcomes and to have the company's LEVADEX(TM) product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results

...to achieve favorable clinical outcomes and to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says

...nfluences -- Research norms dictate that any payments associated with the trial be examined as part of the ethical review process and payments cannot unduly encourage participation. Standard practice is to reimburse for meals, transportation and similar out-of-pocket expenses. To view th...

MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

...to achieve favorable clinical outcomes or to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints

... release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. Actual results may differ materially from current expectations based on risks ...

Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention

... services for children with autism including an initial exam and evaluation for speech therapy. "This is a reasonable new offering which does not unduly create a price impact on customer groups that would affect their ability to continue to provide health care coverage to their employees," Simmer said....

New Virtual Health Assistant Introduced

... to all of our patients. HealtheTrax(TM) gives us the ability to monitor patients through the critical first 12 weeks of treatment and beyond without unduly burdening either the patients or our staff. We see this as the first step towards a more comprehensive sleep management program." "We believe th...

Advocates for Youth Applauds Court Ruling on EC Age Restriction

...about an over-the-counter drug application. Depositions of senior FDA officials by the Center in 2006 indicated that the Bush Administration sought to unduly influence the agency during the Plan B application review process. Testimony also indicated that officials involved in the decision-making process we...

Federal Court Rules FDA Must Reconsider Plan B Decision

...bout an over-the-counter drug application. Depositions of senior FDA officials by the Center in 2006 indicated that the Bush Administration sought to unduly influence the agency during the Plan B application review process. Testimony also indicated that officials involved in the decision-making process we...
unduly in Medical Technology

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

...al use by the U.S. Food and Drug Administration, including but not limited to approval for use as a first line therapy. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting

... uncertainties relating to the development, clinical testing and potential commercialization of our product candidates. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update the...

Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology

... Risk Factors" in the Company's most recent quarterly report on Form 10-Q for the quarter ended March 31, 2008 filed with the SEC. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. The Company undertakes no duty to publicly announce or report re...

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

...elating to the development and commercialization of product candidates incorporating MAP Pharmaceuticals' technologies. The reader is cautioned not to unduly rely on the forward- looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective

...the ClosureFAST catheter, customer and physician preferences, and the experience of other physicians with our products. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward- looking statements except as requ...

Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis

...-K for the year ended December 31, 2006 and updated in Item 1A. Risk Factors in our Form 10-Q for the quarter ended June 30, 2007. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. We undertake no duty to publicly announce or report revisions to...

Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference

... in our report on Form 10-K for the year ended December 31, 2006 as updated in its Form 10-Q for the quarter ended March 31, 2007. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. We undertake no duty to publicly announce or report revisions to...
unduly in Medical Products

WhisperNG Erbium YAG Extended Ablation Laser

Description:...spread over 3-5 days, and occurs simultaneously with the reepithelialization process. The result is a noticeable improvement in skin texture, without unduly exposing the underlying dermis....
Company:Radiancy
unduly in Biological News

Agricultural research key to food security

...take advantage of cutting-edge agricultural technologies, such as genomics and nanotechnology, that have the potential to increase crop yields without unduly stressing the environment. Building such capacity will depend upon overcoming two obstacles: The North-South gap, which delays the transfer of te...

Early administration of antiretroviral therapy can improve survival

...t difficult. With new families of drugs available and new, less toxic combinations, it is now possible to consider instating treatment earlier without unduly affecting the patient's quality of life. The study published in The Lancet , in the framework of the Antiretroviral Therapy Cohort Collaboration ...

Biotechnology needs 21st century patent system: Expert

... Biotechnology discoveries like the method for creating synthetic life forms are at risk of being unduly hindered or taken hostage by private corporations unless patent systems are brought into the 21st century, an expert from The Australian National Univ...
unduly in Biological Technology

MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine

...l outcomes, and that MAP0004 will not be approved for commercial use by the United States Food and Drug Administration. The reader is cautioned not to unduly rely on the forward- looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs

...omes or to have the company's product candidates approved for commercial use by the U.S. Food and Drug Administration. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update th...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

...e ability of VNUS to protect its patent position; and the effectiveness of advertising and other promotional campaigns. The reader is cautioned not to unduly rely on these forward-looking statements. The statements in this press release are made as of the date of this press release, even if subsequently mad...

Codexis, Arch Announce Expanded Collaboration

...lating to commercializing growth; and the challenges of managing growth and establishing effective operations in India. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. We expressly disclaim any intent or obligation to update these forward-looking...

VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance

...position; the effectiveness of advertising and other promotional campaigns; and overall economic and market conditions. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as requi...

Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings

... Risk Factors" in the Company's most recent quarterly report on Form 10-Q for the quarter ended March 31, 2008 filed with the SEC. You should not rely unduly on these forward-looking statements, which apply only as of the date of this release. The Company undertakes no duty to publicly announce or report re...

VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales

...position; the effectiveness of advertising and other promotional campaigns; and overall economic and market conditions. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as requi...

Malaysia Genome Institute Advances Bioinformatics Research Using SGI Technology

...e risks and uncertainties could cause actual results to differ materially from those described in such statements. The reader is cautioned not to rely unduly on these forward-looking statements, which are not a guarantee of future or current performance. Such risks and uncertainties include long-term progra...

MichBio Responds to Governor's Plan to Repeal Tort Reform Laws

...regulatory duties, but allowing for punishment of companies that willfully withhold information or interfere with the drug approval process. Let's not unduly raise the risks for the many due to failures of the few, where current law and tort reform already provides for meaningful recourse to the injured. Mi...

The New Green Revolution offers hope to poor farmers and poor consumers

...uch as organic farming arent a part of the solution. Simply, it is to assert the biotechnology may hold the key to feeding the worlds billions without unduly harming the environment. With a careful eye on unintended consequences, the New Green Revolution must continue, informed protests or not. ...
Other Tags
(Date:12/22/2014)... Only weeks following the announcement that Henderson, Nevada ... a battery manufacturer create 29 well-paying jobs in Mojave ... launching in Henderson to deliver yet another win ... sector is going to build a stronger middle class ... works with small businesses that rely on middle class ...
(Date:12/22/2014)... December 22, 2014 In recognition of ... sales to Hero Reward, a local organization that provides ... , Located on a couple hundred acres ... Program offers lodging, world class fishing, hunting, hiking, horseback ... was founded several years ago to support U.S. Service ...
(Date:12/22/2014)... Pasadena sleep apnea dentist, ... apnea. Drowsy drivers are 15 times more likely to ... and some experts believe that sleep-deprived drivers may be ... Unfortunately, millions of Americans may be sleep-deprived without even ... Medicine, about 18 million Americans have sleep apnea, but ...
(Date:12/22/2014)... Texas (PRWEB) December 22, 2014 7,178 ... and bustle of Black Friday shopping and opted instead ... and marketing education company, for their 5th annual “Black ... charged just $7 to attend the 5 hour ... that they promptly donated to support two Central Texas ...
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again ... provide logistics and support for one of Dallas’ largest holiday ... history of giving back to the community in which it ... Drive were Whataburger® and 99.5 The Wolf. , There is ... gifts to children who would otherwise not receive any is ...
Breaking Medicine News(10 mins):Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... report to their offering. One ... adoption of multimodal biometric systems. Multimodal biometric systems ... for verification and identification purposes. This helps to ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
Other Contents